Advertisement

Topics

340B Pharmacy Policy, Medicaid Payment Rules May Be Targeted For Rescission

13:17 EDT 22 Jun 2017 | SCRIP

Trump administration's drug pricing action plan considers withdrawing guidance and whole or parts of rules that biopharma has opposed.

      

Related Stories

 

Original Article: 340B Pharmacy Policy, Medicaid Payment Rules May Be Targeted For Rescission

NEXT ARTICLE

More From BioPortfolio on "340B Pharmacy Policy, Medicaid Payment Rules May Be Targeted For Rescission"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...